Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Arcus Biosciences, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 211 | 2 | 231 | +22 |
| Shares | 119.1M | 47.7K | 122.7M | +3.62M (+3.0%) |
| Value | $2.57B | $1.03M | $3.78B | +$1.21B (+47.0%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (46)
Institutions that held Arcus Biosciences, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (24)
Institutions that held Arcus Biosciences, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Trails Edge Capital Partners, LP | 1,047,935 | $22.6M |
| Renaissance Technologies LLC | 424,700 | $9.17M |
| Tudor Investment Corp Et Al | 216,311 | $4.67M |
| Point72 Asset Management, L.P. | 129,273 | $2.79M |
| Jane Street Group, LLC | 107,979 | $2.33M |
| Y-Intercept (Hong Kong) Ltd | 86,192 | $1.86M |
| Cantor Fitzgerald, L. P. | 45,000 | $972.0K |
| Qube Research & Technologies Ltd | 38,556 | $832.8K |
| Quadrature Capital Ltd | 32,108 | $693.5K |
| Birchview Capital, LP | 25,889 | $559.2K |
| Aquatic Capital Management LLC | 15,297 | $330.4K |
| Entropy Technologies, LP | 13,612 | $294.0K |
| XTX Topco Ltd | 12,265 | $264.9K |
| Virtu Financial LLC | 9,768 | $211.0K |
| Federated Hermes, Inc. | 1,410 | $30.5K |
| Quadrant Capital Group LLC | 1,088 | $23.5K |
| Sound Income Strategies, LLC | 400 | $8.74K |
| Twin Peaks Wealth Advisors, LLC | 166 | $3.59K |
| Gill Capital Partners, LLC | 50 | $1.08K |
| Annis Gardner Whiting Capital Advisors, LLC | 48 | $1.04K |
| Root Financial Partners, LLC | 40 | $864 |
| MAI Capital Management | 11 | $238 |
| Northwestern Mutual Wealth Management Co | 9 | $194 |
| Advisory Services Network, LLC | 3 | $65 |
Not filed for Q2 2026 yet (2)
Institutions that held Arcus Biosciences, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Janus Henderson Group PLC | 42,338 | $916.4K |
| CWM, LLC | 5,354 | $115.6K |